Oxymetazoline
Active ingredient: Oxymetazoline Hydrochloride
In short: Oxymetazoline hydrochloride cream is indicated for the topical treatment of persistent facial erythema associated with rosacea in adults.
What is Oxymetazoline used for?
Oxymetazoline hydrochloride cream is indicated for the topical treatment of persistent facial erythema associated with rosacea in adults.
Oxymetazoline dosage
For topical use only. Oxymetazoline hydrochloride is not for oral, ophthalmic, or intravaginal use.
Apply a pea-sized amount of oxymetazoline hydrochloride cream, once daily in a thin layer to cover the entire face (forehead, nose, each cheek, and chin) avoiding the eyes and lips. Wash hands immediately after applying oxymetazoline hydrochloride cream.
How to take Oxymetazoline — instructions & advice from the label
Advise the patient and/or caregiver to read the FDA-approved patient labeling
(Patient Information and
Instructions for Use).
Important Administration Instructions
Advise patients of the following:
Oxymetazoline hydrochloride cream is for topical use only.
Do not to apply oxymetazoline hydrochloride cream to irritated skin or open wounds.
Avoid contact with the eyes and lips.
Wash hands immediately after application.
Keep oxymetazoline hydrochloride cream out of reach of children.
Manufactured by: Sun Pharma Canada Inc., Brampton, Ontario, Canada L6T 1C1
Distributed by:
Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512
Revised: December 2025 5217318 1225-01 57
Warnings & precautions
Do not take this medicine if: None.
Alpha-adrenergic agonists may impact blood pressure. Oxymetazoline hydrochloride should be used with caution in patients with severe or unstable or uncontrolled cardiovascular disease, orthostatic hypotension, and uncontrolled hypertension or hypotension. Advise patients with cardiovascular disease, orthostatic hypotension, and/or uncontrolled hypertension/hypotension to seek immediate medical care if their condition worsens.
Oxymetazoline hydrochloride should be used with caution in patients with cerebral or coronary insufficiency, Raynaud's phenomenon, thromboangiitis obliterans, scleroderma, or Sjögren's syndrome. Advise patients to seek immediate medical care if signs and symptoms of potentiation of vascular insufficiency develop.
Oxymetazoline hydrochloride may increase the risk of angle closure glaucoma in patients with narrow-angle glaucoma. Advise patients to seek immediate medical care if signs and symptoms of acute angle closure glaucoma develop.
Oxymetazoline side effects
Because clinical trials are conducted under varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice.
A total of 489 subjects with persistent facial erythema associated with rosacea were treated with oxymetazoline hydrochloride once daily for 4 weeks in 3 controlled clinical trials. An additional 440 subjects with persistent facial erythema associated with rosacea were also treated with oxymetazoline hydrochloride once daily for up to one year in a long-term (open-label) clinical trial. Adverse reactions that occurred in at least 1% of subjects treated with oxymetazoline hydrochloride through 4 weeks of treatment are presented in Table 1 below.
Adverse Reaction | Pooled Controlled Clinical Trials
Oxymetazoline Hydrochloride Cream
(N = 489) | Vehicle Cream
(N = 483)
Application site dermatitis | 9 (2%) | 0
Worsening inflammatory lesions of rosacea | 7 (1%) | 1 (<1%)
Application site pruritus | 5 (1%) | 4 (1%)
Application site erythema | 5 (1%) | 2 (<1%)
Application site pain | 4 (1%) | 1 (<1%)
In the long-term (open-label) clinical trial, the rates of adverse reactions over a one-year treatment period were as follows: worsening inflammatory lesions of rosacea (3%), application site dermatitis (3%), application site pruritis (2%), application site pain (2%), and application site erythema (2%). …
Drug interactions
Alpha-adrenergic agonists, as a class, may impact blood pressure. Caution in using drugs such as beta-blockers, anti-hypertensives and/or cardiac glycosides is advised.
Caution should also be exercised in patients receiving alpha
1 adrenergic receptor antagonists such as in the treatment of cardiovascular disease, benign prostatic hypertrophy, or Raynaud's disease.
Caution is advised in patients taking MAO inhibitors which can affect the metabolism and uptake of circulating amines.
About this medicine
Oxymetazoline hydrochloride cream, 1% contains oxymetazoline hydrochloride, an alpha
1A adrenoceptor agonist. Oxymetazoline hydrochloride is a white to off-white cream. It has a chemical name of 3-[(4,5-Dihydro-1H-imidazol-2-yl)methyl]-6-(1,1-dimethylethyl)-2,4-dimethyl-phenol hydrochloride and a molecular weight of 296.8. It is freely soluble in water and ethanol and has a partition coefficient of 0.1 in 1-octanol/water. The molecular formula of oxymetazoline HCl is C
16H
25CIN
2O and its structural formula is:
Each gram of oxymetazoline hydrochloride cream contains 10 mg (1%) oxymetazoline hydrochloride, equivalent to 8.8 mg (0.88%) of oxymetazoline free base. …
Source: FDA-approved label via DailyMed (U.S. National Library of Medicine), label set ID 8a7f2400-5e18-4215-8d2c-f55881706107. Read the full official label on DailyMed.
Related medicines
Doxycycline Adalimumab Ketoconazole Levocetirizine Cyclosporine Tretinoin Brimonidine Dupilumab